HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 43.95
+0.30 (0.69%)
Jul 30, 2026, 12:49 PM CST
HeXun Biosciences Revenue
In the year 2025, HeXun Biosciences had annual revenue of 293.23M TWD with 2.38% growth. HeXun Biosciences had revenue of 85.26M in the quarter ending December 31, 2025, with 2.90% growth.
Revenue
293.23M
Revenue Growth
+2.38%
P/S Ratio
6.85
Revenue / Employee
5.53M
Employees
53
Market Cap
2.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 293.23M | 6.81M | 2.38% |
| Dec 31, 2024 | 286.42M | 155.85M | 119.36% |
| Dec 31, 2023 | 130.57M | 81.10M | 163.95% |
| Dec 31, 2022 | 49.47M | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.05B |
| Synbio Tech | 1.02B |
| Chunghwa Chemical Synthesis & Biotech | 973.15M |
| G&E Herbal Biotechnology | 261.21M |
| Sunny Pharmtech | 253.01M |
| Gwo Xi Stem Cell Applied Technology Co. , | 187.02M |
| GlycoNex Incorporation | 36.35M |
| Anti-Microbial Savior BioteQ | 706.00K |